ConductScience.org, home
A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
API referenceFor AI assistants

Trial · NCT04182204

Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Safety Run-inSTARTEDStage 1: Pola-R-GemOx15
Safety Run-inSTARTEDStage 2: R-GemOx0
Safety Run-inSTARTEDStage 2: Pola-R-GemOx0
Safety Run-inCOMPLETEDStage 1: Pola-R-GemOx5
Safety Run-inCOMPLETEDStage 2: R-GemOx0
Safety Run-inCOMPLETEDStage 2: Pola-R-GemOx0
Safety Run-inNOT COMPLETEDStage 1: Pola-R-GemOx10
Safety Run-inNOT COMPLETEDStage 2: R-GemOx0
Safety Run-inNOT COMPLETEDStage 2: Pola-R-GemOx0
Randomized Controlled TrialSTARTEDStage 1: Pola-R-GemOx0
Randomized Controlled TrialSTARTEDStage 2: R-GemOx126
Randomized Controlled TrialSTARTEDStage 2: Pola-R-GemOx129
Randomized Controlled TrialSafety-evaluable PopulationStage 1: Pola-R-GemOx0
Randomized Controlled TrialSafety-evaluable PopulationStage 2: R-GemOx125
Randomized Controlled TrialSafety-evaluable PopulationStage 2: Pola-R-GemOx128
Randomized Controlled TrialCOMPLETEDStage 1: Pola-R-GemOx0
Randomized Controlled TrialCOMPLETEDStage 2: R-GemOx32
Randomized Controlled TrialCOMPLETEDStage 2: Pola-R-GemOx55
Randomized Controlled TrialNOT COMPLETEDStage 1: Pola-R-GemOx0
Randomized Controlled TrialNOT COMPLETEDStage 2: R-GemOx94

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04182204/flow

API referenceFor AI assistants